Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
assumed, biotechnology, buy, case, choose, chose, compete, complaint, deconsolidation, delayed, derivative, directed, distribution, District, diversified, domestic, effec, efficacy, Eppendorf, erarchy, exceed, exit, expenditure, face, FAS, final, format, forthcoming, framework, frequently, FSP, globe, good, gradient, herwise, hierarchical, hierarchy, intermediate, irrevocable, mentioned, multianalyte, noncontrolling, nonfinancial, observable, orderly, ot, parent, partial, partially, personal, pharmaceutical, professional, quoted, raw, readily, refurbishment, restructuring, robust, rom, shipped, sourced, specific, standard, subsequent, substantial, substantially, sufficient, tabular, thermocycler, tive, trade, transfer, transparency, treble, trial, true, unobservable, vailable, Western, Wisconsin
Removed:
adequacy, amortized, anniversary, annually, anticipate, anticipated, Applera, Asia, authorize, bank, beef, borrowing, BSE, calendar, charge, classification, competitive, country, curve, deferred, dependant, designated, effected, ESPP, expanded, experiencing, focused, fund, generate, generation, Germany, growing, incentive, intrinsic, issuance, issue, Japan, lesser, longer, marketable, meeting, microbiology, model, modified, month, November, Office, offset, open, paying, performed, prospective, protein, reduce, relating, remained, requisite, retained, safeguard, satisfactory, satisfy, SELDI, settlement, sheet, specialty, sponsored, stated, system, technology, term, transition, treasury, utilizing, vesting, virtually, Volatility, yearly, yield
Filing tables
Filing exhibits
Related press release
BIO similar filings
Filing view
External links
Exhibit 32.1
Certification of Periodic Report
I, Norman Schwartz, Chief Executive Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
(1)
the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2008 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | May 8, 2008 |
| /s/ Norman Schwartz |
|
|
| Norman Schwartz |
|
|
| Chief Executive Officer |